Literature DB >> 8234578

The prevalence of depressive disorders and the distribution of depressive symptoms in later life: a survey using Draft ICD-10 and DSM-III-R.

A S Henderson1, A F Jorm, A MacKinnon, H Christensen, L R Scott, A E Korten, C Doyle.   

Abstract

The point prevalence of depressive disorders was estimated in a sample of persons aged 70 years and over, which included both those living in the community and those in institutional settings. Lay interviewers administered the Canberra Interview for the Elderly to the subjects and their informants. The point prevalence of depressive episodes as defined by the Draft ICD-10 diagnostic criteria was 3.3%. The rate for DSM-III-R major depressive disorder was 1.0%. The latter prevalence rate is similar to those reported elsewhere for the elderly. Evidence is accumulating that older persons may indeed have low rates for depressive disorders at the formal case level. Possible reasons for this finding are offered. A scale for depressive symptoms, based exclusively on those specified in Draft ICD-10 and DSM-III-R, showed that the elderly do experience many depressive symptoms. Contrary to expectation, these did not increase with age. The number of depressive symptoms was correlated with neuroticism, poor physical health, disability and a history of previous depression. Attention now needs to be directed to the clinical significance of depressive symptoms below the case level in elderly persons.

Entities:  

Mesh:

Year:  1993        PMID: 8234578     DOI: 10.1017/s0033291700025496

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  21 in total

1.  [Improvement of knowledge and attitudes towards depression and suicidality in geriatric caregivers: evaluation of an advanced training program].

Authors:  Antje-Kathrin Allgaier; Dietmar Kramer; Roland Mergl; Ulrich Hegerl
Journal:  Z Gerontol Geriatr       Date:  2009-06-28       Impact factor: 1.281

2.  Health, cognitive, and psychosocial factors as predictors of mortality in an elderly community sample.

Authors:  A E Korten; A F Jorm; Z Jiao; L Letenneur; P A Jacomb; A S Henderson; H Christensen; B Rodgers
Journal:  J Epidemiol Community Health       Date:  1999-02       Impact factor: 3.710

3.  Evaluation of the Relationship between Major Depressive Disorder and Bereavement Symptoms in Elderly Patients Who Present Either to Psychiatry or Family Medicine.

Authors:  İbrahim Taymur; Kadir Özdel; Cenk Aypak; Veli Duyan; Özlem Türedi; Buket Belkız Güngör; Yavuz Selvi
Journal:  Noro Psikiyatr Ars       Date:  2016-06-01       Impact factor: 1.339

4.  Does ageing protect against depression?

Authors:  A S Henderson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1994-05       Impact factor: 4.328

Review 5.  Sertraline. A pharmacoeconomic evaluation of its use in depression.

Authors:  R Davis; M I Wilde
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

Review 6.  Designing personalized treatment engagement interventions for depressed older adults.

Authors:  Patrick J Raue; Jo Anne Sirey
Journal:  Psychiatr Clin North Am       Date:  2011-06

Review 7.  The epidemiology of depressive states in the elderly: implications for recognition, intervention and prevention.

Authors:  A F Jorm
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1995-03       Impact factor: 4.328

8.  Period prevalence rates of specific mental disorders in an Icelandic cohort.

Authors:  J G Stefánsson; E Líndal; J K Björnsson; A Guthmundsdóttir
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1994-05       Impact factor: 4.328

Review 9.  The significance of subsyndromal depression in geriatrics.

Authors:  Helen Lavretsky; Kristina Kurbanyan; Anand Kumar
Journal:  Curr Psychiatry Rep       Date:  2004-02       Impact factor: 5.285

Review 10.  Depression in old age. Is there a real decrease in prevalence? A review.

Authors:  C Ernst; J Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.